Genentech · 18 hours ago
2026 Summer Intern – Research Oncology
South San Francisco, CA
Internship
Onsite
Intern
$50/hr - $50/hr
Start in 2026 SummerGenentech is seeking a 2026 Summer Intern in the Department of Research Oncology to join the de Sauvage Lab. The intern will apply molecular biology and computational approaches to study treatment-induced plasticity in colorectal cancer and participate in drug discovery efforts.
BiotechnologyLife ScienceManufacturing
Responsibilities
Work to characterize mechanisms of treatment-related plasticity in cell lines and 3D organoid models of cancer
Analyze ‘omics data to provide insights into mechanisms of tumor suppression
Keep detailed records of the research findings using an electronic notebook
Communicate and present results to a diverse group of scientists during internal meetings
Join a vibrant, rigorous, and industry-leading oncology community
Contribute to a highly innovative project and collaborate productively with researchers across departments at Genentech
Qualification
Required
Must be pursuing a PhD (enrolled student)
Molecular Biology, Cell Biology, Cancer Biology, Biochemistry or related fields
Hands-on research experience in cell biology/biochemistry/molecular biology lab environment is required
Expertise in advanced cell culture techniques such as cell line engineering using CRISPR/Cas9 or PiggyBac transposon systems
Demonstrated ability to be highly motivated and work independently
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Expertise in bulk and single-nucleus RNA-seq and ATAC-seq data analysis (R or Python)
Benefits
Paid holiday time off benefits
Company
Genentech
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.
Founded in 1976
10001+ employees
H1B Sponsorship
Genentech has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)
Funding
Current Stage
Public CompanyTotal Funding
unknown2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown
Leadership Team
Ashley Magargee
Chief Executive Officer
Michael Laird
Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support
Recent News
Bizjournals.com Feed (2025-11-12 15:43:17)
2026-01-21
Company data provided by crunchbase